Literature DB >> 8906876

Tyrosine phosphorylation is crucial for growth signaling by tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2).

K Yamashita1, M Suzuki, H Iwata, T Koike, M Hamaguchi, A Shinagawa, T Noguchi, T Hayakawa.   

Abstract

[3H]Thymidine (TdR) incorporation by human osteosarcoma cell line MG-63 was significantly stimulated at as early as 3 h after the addition of either TIMP-1 or TIMP-2 alone. Maximum stimulation was attained at a concentration of either 20 ng/ml (0.71 nM) TIMP-1 or 1.0 ng/ml (46 pM) TIMP-2. Tyrosine kinase inhibitors such as genistein, erbstatin, and herbimycin A almost completely inhibited the [3H]TdR incorporation stimulated by either of the TIMPs. However, essentially no effect was observed with H-89, H-7, bisindolylmaleimide and K-252a. These inhibition studies suggest a crucial role for tyrosine kinase in the signal transduction of TIMPs. Phosphotyrosine-containing proteins were significantly elevated by the treatment with both TIMPs. We also found that either TIMP stimulated an increase in mitogen-activated protein (MAP) kinase activity, suggesting that MAP kinase plays a role in TIMP-dependent growth signaling.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8906876     DOI: 10.1016/0014-5793(96)01066-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  21 in total

1.  Tissue inhibitor of metalloproteinase-1 alters the tumorigenicity of Burkitt's lymphoma via divergent effects on tumor growth and angiogenesis.

Authors:  L Guedez; A J McMarlin; D W Kingma; T A Bennett; M Stetler-Stevenson; W G Stetler-Stevenson
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

Review 2.  A case of tumor betrayal: biphasic effects of TIMP-1 on Burkitt's lymphoma.

Authors:  L Yan; M A Moses
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

3.  Comparison of metalloproteinase protein and activity profiling.

Authors:  Orsi Giricz; Janelle L Lauer; Gregg B Fields
Journal:  Anal Biochem       Date:  2010-10-23       Impact factor: 3.365

4.  Tissue inhibitor of metalloproteinase-2 stimulates mesenchymal growth and regulates epithelial branching during morphogenesis of the rat metanephros.

Authors:  J Barasch; J Yang; J Qiao; P Tempst; H Erdjument-Bromage; W Leung; J A Oliver
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

Review 5.  The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases.

Authors:  Griselda A Cabral-Pacheco; Idalia Garza-Veloz; Claudia Castruita-De la Rosa; Jesús M Ramirez-Acuña; Braulio A Perez-Romero; Jesús F Guerrero-Rodriguez; Nadia Martinez-Avila; Margarita L Martinez-Fierro
Journal:  Int J Mol Sci       Date:  2020-12-20       Impact factor: 5.923

6.  Enhanced cell surface expression of matrix metalloproteinases and their inhibitors, and tumor-induced host response in progression of human gastric carcinoma.

Authors:  Shohei Koyama
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

Review 7.  Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities.

Authors:  William G Stetler-Stevenson
Journal:  Sci Signal       Date:  2008-07-08       Impact factor: 8.192

8.  Tissue inhibitor of metalloproteinases-1 signalling pathway leading to erythroid cell survival.

Authors:  Elise Lambert; Cédric Boudot; Zahra Kadri; Mahdhia Soula-Rothhut; Marie-Line Sowa; Patrick Mayeux; William Hornebeck; Bernard Haye; Emmanuelle Petitfrere
Journal:  Biochem J       Date:  2003-06-15       Impact factor: 3.857

9.  Overexpression of tissue inhibitors of metalloproteinase 2 up-regulates NF-kappaB activity in melanoma cells.

Authors:  Jun Sun; William G Stetler-Stevenson
Journal:  J Mol Signal       Date:  2009-07-23

10.  Prognostic significance of tissue inhibitor of metalloproteinase-1 in breast cancer.

Authors:  Arunee Dechaphunkul; Monlika Phukaoloun; Kanet Kanjanapradit; Kathryn Graham; Sunita Ghosh; Cheryl Santos; John R Mackey
Journal:  Int J Breast Cancer       Date:  2012-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.